Company profile: Fluoresentric
1.1 - Company Overview
Company description
- Provider of assay design, optimization, and custom manufacturing services for the healthcare and biotechnology sector.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Fluoresentric
Biocure Technology
HQ: Canada
Website
- Description: Provider of biosimilars and CAR-T cell pharmaceutical products.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Biocure Technology company profile →
Immtech Pharma
HQ: United States
Website
- Description: Provider of biopharmaceutical therapeutics, focusing on the discovery and commercialization of treatments for patients.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Immtech Pharma company profile →
IQuum
HQ: United States
Website
- Description: Provider of molecular diagnostics and biological sample technology, developing an early-stage platform to improve extraction of information from biological samples and deliver recent advances in genomics and biotechnology to healthcare and daily life; founded in 1998 in the Boston metropolitan area.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full IQuum company profile →
Sequella
HQ: United States
Website
- Description: Provider of biopharmaceutical products for diagnosing and treating epidemic infectious diseases, including SQ109 (Phase 2 for multidrug-resistant pulmonary tuberculosis), Sutezolid (oxazolidinone in clinical development for tuberculosis), SQ609 (preclinical for tuberculosis), SQ641 (preclinical for C. difficile and nontuberculous mycobacteria), B-SMART rapid TB susceptibility tests, and small-molecule and natural product drug discovery programs.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Sequella company profile →
Lodo Therapeutics
HQ: United States
Website
- Description: Provider of drug discovery and development focused on creating naturally derived novel therapeutics to impact global human health, working in partnership with global pharmaceutical companies and leading NGOs.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Lodo Therapeutics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Fluoresentric
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Fluoresentric
2.2 - Growth funds investing in similar companies to Fluoresentric
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Fluoresentric
4.2 - Public trading comparable groups for Fluoresentric
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →